Skip to content

Omega-3 trials did not establish lower organ rejection after transplantation

A review found some favorable blood pressure and cholesterol results, but no statistically significant reduction in its primary outcome: graft rejection.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The review did not find a statistically significant reduction in transplant rejection with omega-3 supplementation. Some blood pressure and cholesterol measures improved, with findings varying by transplanted organ and outcome. Those changes do not establish protection against rejection, and the nonsignificant rejection results do not prove that supplementation has no possible effect.

Keep in mind

The authors cite variation between studies and limited outcome data. The abstract does not provide rejection effect estimates, confidence intervals, or control details, making it difficult to judge how much benefit or harm remains compatible with the results.

THE RESULT, WITH CONTEXT

What researchers found

No statistically significant reduction

Graft rejection

Rejection results at 30 days, 3 months, and 1 year after transplantation did not significantly favor omega-3 supplementation. The trial comparator conditions are not reported in the abstract.

Clin Nutr ESPEN, 2025 · Original source ↓

Separate the outcomes

Rejection was the primary outcome. Favorable secondary findings included diastolic blood pressure and total cholesterol, particularly among kidney recipients, and systolic blood pressure among heart recipients; these answer different clinical questions.

Results were uneven

Findings for other lipids and kidney-function measures were inconsistent and mostly nonsignificant. The abstract also reports no significant effect on calcineurin inhibitor toxicity, reinforcing that the review did not show a uniform benefit.

CHECK THE ORIGINAL

The original publication

Omega-3 fatty acid supplementation in solid organ transplant recipients: A systematic review and meta-analysis of randomized controlled trials.

Samankan S, Gharekhani A, Khiali S et al.
Clin Nutr ESPEN · 2025

PubMed ID
40912359
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.